BAZOCAR 300 TABLET

Product Description

BAZOCAR 300 TABLET Effective Antiepileptic Therapy with Oxcarbazepine 300mg

Product Description:

BAZOCAR 300 Tablet contains Oxcarbazepine 300mg, a potent anticonvulsant widely prescribed for the treatment of partial seizures and epilepsy. Known for its high efficacy and improved safety profile, Oxcarbazepine helps stabilize abnormal electrical activity in the brain, reducing seizure frequency and improving patient quality of life.

Manufactured under stringent WHO-GMP and DCGI-approved standards, BAZOCAR 300 is an ideal choice for neurologists, hospitals, pharmaceutical distributors, and bulk buyers aiming to offer reliable seizure control solutions.

Key Benefits:

• Controls partial-onset seizures in adults and children

• Exhibits better tolerability and fewer side effects than older antiepileptics

• Suitable for monotherapy or adjunctive therapy in epilepsy management

• Promotes improved patient compliance with once or twice-daily dosing

• Backed by robust clinical evidence and regulatory approvals

Indications:

• Management of partial seizures with or without secondary generalization

• Adjunct treatment for epilepsy in pediatric and adult patients

Ideal For:

• Neurology clinics & hospitals

• Pharmaceutical wholesalers & retail chains

• Bulk procurement & institutional supplies

• Exporters & pharmaceutical franchise partners

Packaging:
Blister Packs | Customized bulk packaging available
Certifications: WHO-GMP | DCGI Approved | ISO Certified
Shelf Life: 2436 months

BAZOCAR 300 Tablet by Agrosaf Pharmaceuticals Pvt. Ltd. combines clinical efficacy with safety, making it the preferred choice for comprehensive epilepsy management. Perfect for B2B pharmaceutical distributors, tenders, and healthcare institutions seeking quality anticonvulsants.